Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.72EUR
130.59 MEUR
1.11 BEUR
43.66 M
About KOBAYASHI PHARMACEUTICALS
Sector
Headquarters
Osaka
Employees (FY)
3.53 K
Website
Founded
1886
ISIN
JP3301100008
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KOY is 32.60 EUR — it hasn't changed in the past 24 hours. Watch KOBAYASHI PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange KOBAYASHI PHARMACEUTICAL CO LTD stocks are traded under the ticker KOY.
KOBAYASHI PHARMACEUTICAL CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
KOY stock is 0% volatile and has beta coefficient of 0.46. Track KOBAYASHI PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is KOBAYASHI PHARMACEUTICAL CO LTD there?
KOY earnings for the last quarter are 0.36 EUR per share, whereas the estimation was 0.36 EUR resulting in a 0% surprise. The estimated earnings for the next quarter are 0.33 EUR per share. See more details about KOBAYASHI PHARMACEUTICAL CO LTD earnings.
KOBAYASHI PHARMACEUTICAL CO LTD revenue for the last quarter amounts to 348.91 M EUR despite the estimated figure of 351.47 M EUR. In the next quarter revenue is expected to reach 224.20 M EUR.
Yes, you can track KOBAYASHI PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
KOY stock has fallen by 1.81% compared to the previous week, the month change is a 1.21% fall, over the last year KOBAYASHI PHARMACEUTICAL CO LTD has showed a 41.79% decrease.
KOY net income for the last quarter is 31.06 M EUR, while the quarter before that showed 48.33 M EUR of net income which accounts for −35.72% change. Track more KOBAYASHI PHARMACEUTICAL CO LTD financial stats to get the full picture.
Today KOBAYASHI PHARMACEUTICAL CO LTD has the market capitalization of 2.39 B, it has decreased by 1.27% over the last week.
KOBAYASHI PHARMACEUTICAL CO LTD dividend yield was 1.49% in 2023, and payout ratio reached 37.66%. The year before the numbers were 1.00% and 34.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, KOY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOBAYASHI PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of May 10, 2024, the company has 3.53 K employees. See our rating of the largest employees — is KOBAYASHI PHARMACEUTICAL CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOBAYASHI PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOBAYASHI PHARMACEUTICAL CO LTD stock shows the sell signal. See more of KOBAYASHI PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KOBAYASHI PHARMACEUTICAL CO LTD future price: according to them, KOY price has a max estimate of 53.47 EUR and a min estimate of 34.46 EUR. Watch KOY chart and read a more detailed KOBAYASHI PHARMACEUTICAL CO LTD stock forecast: see what analysts think of KOBAYASHI PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOBAYASHI PHARMACEUTICAL CO LTD EBITDA is 204.43 M EUR, and current EBITDA margin is 18.36%. See more stats in KOBAYASHI PHARMACEUTICAL CO LTD financial statements.